Focused on your needs

Our mission is to be a global leader in generics and biopharmaceuticals, improving the lives of patients across the world

In a complex world, Teva's mission is simple: to improve the lives of patients across the globe. We believe that everyone should have access to quality medicines whether it be for managing disease, fighting infections, or simply improving overall health.

For more than a century healthcare providers, patients and caregivers have been using Teva’s medicines. We save patients and healthcare systems billions of euros every year by offering accessible generic alternatives to branded treatments. 

We are proud that since Teva’s establishment in 1901, healthcare providers together with patients and caregivers have been using our accessible generic and innovative products. Today, our portfolio of around 3,500 products is among the largest of any pharmaceutical company in the world. 01 Nearly 200 million people in 60 countries benefit from one of Teva's quality medicines every day.02

We invest in research and development of generic medicines and biopharmaceuticals, carrying on the legacy of more than a century of finding new ways to help patients improve their lives. This defines our values as a company and characterises how we do business and approach medicine.

Today, Teva is the leading generic drug company in Ireland and the largest supplier of prescription medicines to Ireland’s pharmacies. 03 Approximately one of every five generic prescriptions in Ireland is filled with a Teva product.04


Teva in Ireland

Our colleagues across Ireland are working hard to improve patients' health

Discover more

Our medicines

We provide high-quality generic and specialty medicines here in Ireland and around the world

Learn more

References

  1. Back to contents.

    Teva Global Operations - Internal Data Source

  2. Back to contents.

    Internal analyses conducted by Global Insights, Access & Technologies estimating number of Teva consumers. dated Aug 2016 and Apr 2019

  3. Back to contents.

    Teva UK - Data on file

  4. Back to contents.

    Teva UK - Data on file

Share this article:

Date of preparation: November 2021
Reference: COB-IE-NP-00018